Last week’s headlines included results sports nutrition brand GymBeam’s strategy for building its EU footprint, TGA’s new guidance on NMN, NAD+, NAD and NADH labeling, and growth of sexual wellness supplements.
GymBeam builds European footprint
Sports nutrition retailer and brand GymBeam claims to have established itself as the largest European retailer of supplements after investing in warehouse robotics, AI and delivering on trends for sports nutrition, GLP-1 support and longevity.
The Slovak-founded company reported a 24% increase in revenue between January and December in 2025, while EBITDA rose 35% year-on-year to €18.7 million.
According to its most recent annual report, GymBeam’s gross margin increased from 45% in 2024 to 48.48% in 2025, with the growth largely driven by use of new technologies, in-house production, and on-trend innovation.
The company’s focus on core sports nutrition staples, new product launches, and functional foods for GLP-1 support, alongside the acquisition of German manufacturer Kaja Food, strengthened its product portfolio and margins.
Automation in logistics and customer service reduced costs and improved efficiency, notably with a new Milan fulfillment center and AI-driven processes. Expansion efforts prioritized Western Europe, with significant growth in Italy, Czechia, and Slovakia, supported by influencer partnerships and regional market adaptation.
Australia’s TGA releases guidance on NMN, NAD+ and NADH product naming
Australia’s Therapeutic Goods Administration (TGA) has issued new guidance on how NMN, NAD+, NAD and NADH can be represented in health supplements, with implications for naming, labeling and advertising requirements.
Aside from NMN, nicotinamide and nicotinamide riboside chloride (NR), other ingredients related to the nicotinamide adenine dinucleotide (NAD+) conversion chain, such as NAD, NAD+ itself and NADH, are not yet permitted for use in complementary medicines sold in Australia.
NAD+ precursor ingredients have seen rapid growth across the Asia-Pacific region, particularly in China, where they have gained popularity since 2020 amid growing interest in anti-aging and longevity claims.
Prior to last year’s approval of NMN, Australian consumers could purchase their products through cross-border e-commerce, also known as the personal importation scheme in Australia.
“This means Australian businesses are not always competing on a level playing field,” said Rhiona Robertson, general manager at product development and regulatory agency Healthcare Product Specialists. “They can invest significantly in regulatory compliance, Australian manufacturing, packaging and marketing, while competing for the same consumer against imported products operating under very different regulatory requirements.”
Sexual wellness supplements gain ground
Sexual wellness may be edging further into the supplement mainstream as consumer interest in products spanning intimate health, beauty and healthy aging create new territory for brands.
New survey data from sexual wellness company Lelo found that 72% of US respondents were interested in products crossing the boundaries between beauty and sexual wellness.
Among consumers interested in the crossover, 44% cited supplements, behind ingredient-conscious intimate care products at 50% and at-home LED intimate devices at 47%.
Industry experts said the crossover was playing into established supplement categories, including hormonal health, stress support, microbiome health and healthy aging. But sexual wellness supplements remained an emerging category, and scientific substantiation would need to keep pace with consumer interest and product development.
Scott Dicker, senior director of market insights at SPINS, said the market intelligence company was seeing a wider convergence of beauty, wellness and self-care across the natural products industry.
“Consumers increasingly view health holistically rather than through isolated categories, creating opportunities for products that address multiple dimensions of well-being simultaneously,” he said.
